KEQU

$33.83+1.29%visit website

KEWAUNEE SCIENTIFIC CORP /DE/

Market Cap

$98M

Live price × SEC shares (Sep 8, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.81

60mo monthly vs SPY

P/E (TTM)

12.3

TTM to Jul 2026 · diluted EPS

P/S (TTM)

0.4

TTM to Jul 2026 · revenue

P/B

1.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

5.1

TTM to Jul 2026 · EV incl. net debt

Loading…

Financial Statements

USD thousands	Q2 FY2026 Oct 31, 2025	Q3 FY2026 Jan 31, 2026	Q4 FY2026 Apr 30, 2026	Q1 FY2027 Jul 31, 2026	TTM Jul 31, 2026
Revenue	70,096	69,399	71,400	66,320	277,215
Cost of revenue	50,376	50,854	50,155	46,681	198,066
Gross profit	19,720	18,545	21,245	19,639	79,149
Total operating expenses	15,613	15,963	16,029	16,481	64,086
Operating income	4,107	2,582	5,216	3,158	15,063
Interest expense	1,061	1,112	631	626	3,430
Pretax income	3,453	1,604	4,756	2,560	12,373
Income tax	915	528	1,064	717	3,224
Net income	2,445	692	3,388	1,706	8,231
EPS (basic) ($)	0.85	0.24		0.59	2.87
EPS (diluted) ($)	0.82	0.23		0.58	2.76
Weighted avg. shares (basic)	2,866	2,866		2,880
Weighted avg. shares (diluted)	2,990	2,983		2,921

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Sep 11, 2026, period ended Jul 31, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jul 2010, with Tormere Pro.

Corporate Events (8-K)

12 filings in 12 months · 1 with priority itemsFull history →

Filed	Items	Filing
Nov 2, 2026 accepted 9:00 AM ET	1.01Material agreement3.02Unregistered equity sale7.01Reg FD disclosure	Document SEC ↗
Sep 9, 2026 accepted 4:19 PM ET	2.02Earnings release	Document SEC ↗
Aug 27, 2026 accepted 7:58 AM ET	5.07Shareholder vote	Document SEC ↗
Aug 26, 2026 accepted 6:10 AM ET	7.01Reg FD disclosure	Document SEC ↗
Aug 25, 2026 accepted 4:20 PM ET	8.01Other events	Document SEC ↗
Jun 23, 2026 accepted 5:10 PM ET	2.02Earnings release	Document SEC ↗
Jun 10, 2026 accepted 4:07 PM ET	8.01Other events	Document SEC ↗
Mar 11, 2026 accepted 4:05 PM ET	2.02Earnings release	Document SEC ↗
Feb 25, 2026 accepted 4:06 PM ET	8.01Other events	Document SEC ↗
Dec 10, 2025 accepted 4:09 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

23%

W/W -19.7pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-01-07	2026-01-08	HULL THOMAS DAVID III	Director & President, CEO	Sale	2,177	$37.50	$82K	33.0K	View
2026-01-06	2026-01-07	Gardner Donald T. III	Chief Financial Officer	Sale	2,000	$37.57	$75K	9,564	View
2025-12-31	2026-01-02	HULL THOMAS DAVID III	Director & President, CEO	Sale	629	$37.66	$24K	35.2K	View
2025-12-30	2026-01-02	HULL THOMAS DAVID III	Director & President, CEO	Sale	29	$38.00	$1K	35.8K	View
2025-12-29	2025-12-31	HULL THOMAS DAVID III	Director & President, CEO	Sale	884	$38.01	$34K	35.8K	View